n/a
Article Publish Status: FREE
Abstract Title:

Ginsenoside-Rb1 for Ischemic Stroke: A Systematic Review and Meta-analysis of Preclinical Evidence and Possible Mechanisms.

Abstract Source:

Front Pharmacol. 2020 ;11:285. Epub 2020 Mar 31. PMID: 32296332

Abstract Author(s):

Yi-Hua Shi, Yan Li, Yong Wang, Zhen Xu, Huan Fu, Guo-Qing Zheng

Article Affiliation:

Yi-Hua Shi

Abstract:

Background: Ischemic stroke is the most common type of stroke, while pharmacological therapy options are limited. Ginsenosides are the major bioactive compounds in Ginseng and have been found to have various pharmacological effects in the nervous system. In the present study, we sought to evaluate the effects of Ginsenoside-Rb1 (G-Rb1), an important ingredient of ginsenosides, and the probable neuroprotective mechanisms in experimental ischemic strokes.

Methods: Studies of G-Rb1 on ischemic stroke animal models were identified from 7 databases. No clinical trials were included in the analysis. The primary outcome measures were neurological function scores, infarct volume, evans blue content and/or brain water content (BWC). The second outcome measures were the possible neuroprotective mechanisms. All the data were analyzed by Rev Man 5.3.

Result: Pooled preclinical data showed that compared with the controls, G-Rb1 could improve neurological function (Zea Longa (n = 367, P<0.01); mNSS (n = 70, P<0.01); Water maze test (n = 48, P<0.01); Bederson (n = 16, P<0.01)), infarct area (TTC (n = 211, P<0.01); HE (n = 26, P<0.01)), as well as blood-brain barrier function (BWC (n = 64, P<0.01); Evans blue content (n=26, P<0.05)). It also can increase BDNF (n = 26, P<0.01), Gap-43 (n = 16, P<0.01), SOD (n = 30, P<0.01), GSH (n = 16, P<0.01), Nissl-positive cells (n = 12, P<0.01), Nestin-positive cells (n = 10, P<0.05), and reduce Caspase-3 (n = 36, P<0.01), IL-1 (n = 32, P<0.01), TNF-α (n = 72, P<0.01), MDA (n = 18, P<0.01), NO (n = 44, P<0.01), NOX (n = 32, P<0.05), ROS (n = 6, P<0.05), NF-κB (P<0.05) and TUNEL-positive cells (n = 52, P<0.01).

Conclusion: Available findings demonstrated the preclinical evidence that G-Rb1 has a potential neuroprotective effect, largely through attenuating brain water content, promoting the bioactivities of neurogenesis, anti-apoptosis, anti-oxidative, anti-inflammatory, energy supplement and cerebral circulation.

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.